Pharmacological approaches to acute ischaemic stroke: reperfusion certainly, neuroprotection possibly
Stroke is a major cause of both death and disability. However, there are no pharmacological treatments used in most countries other than recombinant tissue plasminogen activator, a thrombolytic, and this is only used in about 4% of patients presenting after an acute ischaemic stroke. One novel throm...
Uloženo v:
| Hlavní autor: | |
|---|---|
| Médium: | Revisão |
| Jazyk: | angličtina |
| Vydáno: |
2007
|
| On-line přístup: | https://doi.org/10.1038/sj.bjp.0707594 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|